Effect of rosiglitazone on homocysteine and creatinine levels in patients with type 2 diabetes.
Stulc
Tomas
T
Kasalova
Zdislava
Z
Krejci
Hana
H
Dolezalova
Radka
R
Ceska
Richard
R
D015415:Biomarkers / Q000097:blood; D003404:Creatinine / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006710:Homocysteine / Q000097:blood* / Q000187:drug effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use*
D015415:Biomarkers; D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D006710:Homocysteine; D003404:Creatinine